Southeast Asia is an emerging hotspot for COVID-19.

Chookajorn, Thanat; Kochakarn, Theerarat; Wilasang, Chaiwat; Kotanan, Namfon; Modchang, Charin

Chookajorn, Thanat; Kochakarn, Theerarat; Wilasang, Chaiwat; Kotanan, Namfon; Modchang, Charin.

Chookajorn T; COVID-19 Network Investigations Alliance, Bangkok, Thailand. thanat.cho@mahidol.edu.
Kochakarn T; Genomics and Evolutionary Medicine Unit, Center of Excellence in Malaria Research, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand. thanat.cho@mahidol.edu.
Wilasang C; Molecular Infection Medicine Sweden, Molecular Biology Department, Umeå University, Umeå, Sweden. thanat.cho@mahidol.edu.
Kotanan N; COVID-19 Network Investigations Alliance, Bangkok, Thailand.
Modchang C; Molecular Infection Medicine Sweden, Molecular Biology Department, Umeå University, Umeå, Sweden.

Nat Med ; 27(9): 1495-1496, 2021 09.

Article in English | MEDLINE | ID: covidwho-1360204

Subject(s)

COVID-19/epidemiology; Disease Hotspot; Mass Vaccination/statistics & numerical data; SARS-CoV-2/genetics; Asia, Southeastern/epidemiology; COVID-19 Vaccines/therapeutic use; Genome, Viral/genetics; Humans; Socioeconomic Factors; Transients and Migrants

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Mass Vaccination / Disease Hotspot / SARS-CoV-2 / COVID-19 Type of study: Observational study Topics: Vaccines Limits: Humans Country/Region as subject: Asia Language: English Journal: Nat Med Journal subject: Molecular Biology / Medicine Year: 2021 Document Type: Article Affiliation country: S41591-021-01471-x

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google